SPICY aims at creating a new and profitable value chain in the Flemish bio-economy by connecting sugar feedstock suppliers with fermentation-based and chemical biorefinery companies to end-users active in chemical and polymer production.
The MARISURF project will use marine bacterial strains to produce new SAs. To ensure the newly discovered SAs satisfy their requirements and demands, MARISURF will place the industrial end-users in a leading role in guiding the search for new SAs.
The BioBase4SME project intends to help Start-ups and SME to overcome technological and non-technological barriers to bring their innovation to market.
The CARBOSURF project aims to develop new biobased processes as well as products and solves bottlenecks in the fermentative production of biobased biosurfactants and specialty carbohydrates. Specifically, it targets different glycolipid biosurfactants with a wide range of application fields and specialty carbohydrates, i.e. complex Human Milk Oligosaccharides that find applications as neutraceutical, pharmaceutical and cosmetic ingredients. The project is coordinated by Prof. Soetaert from Ghent University (Belgium).
The Nano3Bio project aims to develop biotechnological production systems for nanoformulated chitosans. Chitosans are among the most versatile and most promising biopolymers and have excellent physico-chemical and material properties as well as a wide range of biological functionalities.
IB2Market aims to bring industrial biotechnology from the research lab to the market and to solve the bottle-necks in industrialization. The project covers process development, scale up, market exploration and the drafting of a valorization plan to support a successful market introduction.
The ChitoBioEngineering project aims at establishing biotechnological ways of producing fully defined, partially acetylated chitosan oligomers. This will be achieved through genetic, metabolic, and enzyme engineering.
Industrial biotechnology plays a crucial role in the development of sustainable and cost effective production processes for biobased chemicals. These processes typically consist of two distinct unit operations: fermentation, followed by purification of the compound of interest from the fermentation broth. Product recovery and purification (also called downstream processing or DSP) are important cost factors, responsible for up to 80% of the total production cost. Reducing DSP cost is therefore a key success factor to improve the overall economics of biobased processes.
The goal of the Novosides project is the development of biocatalytic processes for the glycosylation of small organic molecules such as flavonoids, alkaloids and steroids. Glycosylation can drastically improve both the physicochemical and biological properties of these molecules (e.g. slow release, improved solubility and stability, taste modification, drug targeting), but few biocatalysts are currently available to perform this modification cost-efficiently at industrial scale.